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Background: Aconitum is an indispensable entity of the traditional medicine therapy in Ayurveda and Traditional
Chinese medicine (TCM), in spite of its known fatal toxicity characteristics. The prolonged use of this drug,
irrespective of its known lethal effects, is governed by the practice of effective detoxification processes that have
been used for decades. However, the processing methods of Ayurveda and TCM are different, and no comparative
study has been carried out to evaluate their differences.
The objective of the present study was to carry out comparative chemical profiling of the roots of Aconitum
heterophyllum Wall, A. carmichaelii Debx., and A. kusnezoffii Reichb. after application of two detoxification methods
used in Ayurveda and one method used in TCM .
Results: Analysis of the processed samples was carried out by ultra-high performance liquid chromatography
combined with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS). The results obtained in the study
demonstrate that all three processing methods used in Ayurveda and TCM effectively extract the diester
diterpenoid alkaloids and led to their conversion into monoester diterpenoid alkaloids. The efficiency of the
processes in reduction of toxic alkaloid contents can be stated as: Processing with water > Shodhana with cow milk
> Shodhana with cow urine. The analysis method was validated as per ICH-Q2R1 guidelines and all the parameters
were found to comply with the recommendations stated in the guidelines.
Conclusions: There have been no reports till date, to compare the processing methods used in Ayurveda with the
methods used in TCM for detoxification of aconite roots. Our study demonstrates that, these methods used in both
the traditional systems of medicine, efficiently detoxify the aconite roots. Amongst the three selected procedures,
the TCM method of decoction with water is the most efficient. Through experimental evidences, we prove the
conversion of toxic diester diterpenoid alkaloids to relatively safer monoester diterpenoid alkaloids. Thus, this study
demonstrates that comparative study on the traditional experiences accumulated in different medical systems is
useful for expanding their respective applications.
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For centuries, Aconite has been highly regarded in the trad-
itional medicine of China (TCM) and of India (Ayurveda)
[1,2]. The genus Aconitum (family Ranunculaceae) has
more than 300 species worldwide, of which more than 166
are found in China and India [3,4]. The roots of Aconitum
heterophyllum Wall (Atis) are used as medicine in India,
and its preparations are mentioned in the Ayurvedic
Pharmacopoeia and Ayurvedic formulary of India [5,6].
The processed roots of A. carmichaelii Debx. (Zhichuanwu)
and A. kusnezoffii (Zhicaowu) have been widely used
in China and are listed in the Chinese Pharmacopoeia
[7]. These plants are used for treating rheumatalgia,
rheumatic arthritis, cold, pain and other ailments
[6-11].
As is well known, the unprocessed Aconite root, if
ingested, causes fatal toxicities [9-11]. In India and
China, many medicinal herbs are subjected to specific
treatments before they are used as materia medica. The
history of the alchemy of aconite processing in India
dates back to the 5th and 6th centuries, and received
wide acceptance during the 8th and 9th centuries A.D.
After the 8th century the ancient science of pharmacy
called “Rasashastra” was used routinely by herbal medi-
cal practitioners. Processing methods in Ayurveda
(called Samskaras) consist of two stages: The Shodhana
(purification or detoxification) and Bhaishajya kalpana
(formulation methods). The process of Shodhana involves
treatment of the drug with “Goumutra” (cow urine) and
cow milk [12-16]. About 200 medical texts that describe
the Shodhana process, have been written in various
languages. Amongst these 200 published texts, “Charaka
Samhita” is said to establish the basic concepts for pro-
cessing herbal medicines [12-15].
In the ancient TCM records, various methods for
detoxification of Aconite roots and 600 different formu-
lations prepared from processed aconite are documented
[17]. The use of the processed form of aconitum was
first documented in the ‘Shennong Materia Medica’
(Sheng-nong Ben Cao Jing) written in the Eastern Han
Dynasty (24–220 AD); and this herb is an integral part
of traditional medicine practices for treatment of arthral-
gia, colds, cardiac problems, diarrhoea, and oedema [18].
Two classic ancient monographs, namely Lei Gong
Processing Handbook (Lei Gong Pao Zhi Lun, written in
500 AD) and Processing Methodology (Pao Zhi Da Fa,
published in 1662), have mentioned the processing
method of Aconite roots [19,20]. According to the
Chinese pharmacopoeia (2010 edition), various proce-
dures involving treatment with mineral salt water and
decoction with water were recorded for processing the
roots of A. carmichaelii and A. kusnezoffii to produce
the medicinal products called “Fuzi” and “Zhicaowu”,
respectively [7,17]. Among those processing methods,boiling with water for processing the roots of Aconite is
the simplest methods and is selected for the present
comparative study.
The specific treatments claim to enhance the efficacy
and reduce the toxicity of crude drugs by alteration of
their pharmacodynamic properties. For Aconite roots,
the pharmacodynamic and toxicity level changes occur
due to modifications in the structures of Diester Diter-
penoid Alkaloids (DDA’s) after processing, leading to
formation of monoester diterpenoid alkaloids (MDA’s)
[21-23]. The reaction hypothesised for these changes in
the chemistry of Diester Diterpenoid Alkaloids is in-
dicated in Figure 1 [17,24]. There have been several
pharmacological studies that demonstrate the reduction
in the toxicity of the processed aconitum due to Shod-
hana treatment [22,25]. Although this process has been
used for more than 200 years, the alchemy behind these
processing strategies still lacks evidence-based scientific
validation and needs further understanding. Moreover,
there have been no chemical profiling studies that can
substantiate and verify the chemical transformations
resulting in radical reduction in the toxicity of Aconitum
due to Shodhana.
The Shodhana process is not particularly mentioned
only for processing of Aconitum heterophyllum in the
Ayurvedic Pharmacopoeia of India. There have been no
reports published for the quantitation of toxic alkaloids
of these three species of Aconitum processed by Shod-
hana method and for the comparative study of the two
traditional processing methods. In contrast, the TCM
processes have been explored extensively through phar-
macological and analytical studies [8,24-33]. Toxicity of
nine types of decoction pieces from the daughter root of
A. carmichaelii (Fuzi) based on chemical analysis of
diester diterpenoid alkaloids was assessed in our previ-
ous study [28].
The aim of the present study was to carry out a
comparative study of these two detoxification me-
thods belonging to two different traditional systems
of medicine, with a view of providing insights into
the changes in the phytochemical composition of the
processed forms. The changes were studied with re-
spect to the most toxic components of Aconite viz.
aconitine, mesaconitine, and hypaconitine used as
markers in the study, as these are the major deter-
minants of aconite toxicity. A ultra-high performance
liquid chromatography combined with quadrupole
time-of-flight mass spectrometry (UHPLC-Q-TOFMS)
method, that has advantages of high sensitivity and
mass accuracy over other chromatographic detection
methods, was used for the analysis of the samples.
The method used was developed and validated as per
ICH (Q2-R1) guidelines for validation of analytical
methods [34].
A B R1 R2
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Figure 1 Structural changes affected by hydrolysis leading to detoxification of toxic aconitum alkaloids.
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Validation of the developed analytical method
The method developed for analyzing the detoxified sam-
ples was validated as per ICH guidelines Q2R1. A pictor-
ial representation of the detoxification strategy used is
shown in Figure 2, and the LC-MS spectra of marker
compounds are shown in Figure 3.
The linearity ranges for all marker compounds were es-
timated, and satisfactory regression coefficient (r2 ≥ 0.99)
values were obtained for all three selected markers. The
calibration ranges for aconitine (r2 = 0.9988), mesaconitine
(r2 = 0.9994) and hypaconitine (r2 = 0.9990) were between
2.0 – 100 ng mL-1. The calibration curve equations
obtained for all the three markers are shown in Table 1.
The limits of detection (LOD) of aconitine, mesaconitine
and hypaconitine were found to be 0.383 ng mL-1,
0.438 ng mL-1 and 0.088 ng mL-1, respectively. The limits
of quantitation (LOQ) for aconitine, mesaconitine and
hypaconitine were 1.15 ng mL-1, 1.31 ng mL-1 and
0.264 ng mL-1 respectively. All the determinations were
carried out with sample concentrations within the cali-
bration range selected for each marker compound. The
representative Extracted Compound Chromatogram (ECC)
chromatogram, Molecular Feature Extraction (MFE) spec-
trum, and Total Ion Chromatogram (TIC) overlay spectra
of markers along with Base Peak Chromatogram (BPC) of
methanol used as solvent are shown in Figure 3.
The precision studies were carried out with three
assays, the Interday precision, Intraday precision, and
repeatability. The average contents for all markers were
calculated for each determination, and the values are
indicated in Table 2. All the RSD values are expressed as
percentages, and all of them fall within the limits (≤ 5%)as stated by the ICH guidelines. For Interday precision,
the % RSD values (n = 3) for aconitine, mesaconitine and
hypaconitine were found to be 0.037, 0.064, and 0.107,
respectively. For Intraday precision, the% RSD values
(n = 5) for aconitine, mesaconitine and hypaconitine
were 0.243, 0.249 and 0.477, respectively. The repeatability
studies were carried out with 5 replicate determinations of
the same samples weighed individually five times. The
values of % RSD (n = 5) obtained in repeatability studies
for aconitine, mesaconitine and hypaconitine were 0.530,
0.324 and 0.200%, respectively. The results obtained
suggest that the developed method is precise enough to
measure the contents in close precision for replicate
analysis within the same day, for three consecutive days
and for multiple measurements of the same sample on the
same day using the optimized chromatographic parame-
ters of the method.
The recovery study for all the three marker com-
pounds was performed at three levels by adding standard
compounds at 50, 100 and 150% of their concentrations
in the sample. The results of recovery study are shown
in Table 3. Overall, the recoveries were found to be
within the range of 85-108% of the expected concentra-
tions of the standards. Results indicate that the method
is accurate and precise enough to recover the com-
pounds of interest from a complex herbal sample matrix.
Thus, based upon the results obtained for the validation
parameters, we suggest that the validated method can be
used for the present study.
The representative LC-MS BPC chromatograms of all
the samples indicating the profiles of various compo-
nents are shown in Figures 4, 5, 6 and Additional file 1:
Figures S1, Additional file 2: Figure S2, Additional file 3:
Figure 2 Representation of Shodhana and TCM detoxification process applied for selected Aconitum species (A) Drug treated with
cow urine (B) Drug boiled in cow milk (C) Pre-soaked drug subjected to decoction with water.
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uents in the samples were identified, that included 44
known components and 6 unknown components repre-
sented in the additional data files (Additional file 4:
Table S1 of additional data file). The marker compounds
in samples were estimated by comparing the retention
times and mass-to-charge (m/z) ratios with the reference
standards. Aconitine and mesaconitine exhibited reten-
tion times of 14.5 min and 13.5 min with mass-to-
charge (m/z) ratios of 646.322 and 632.306, respectively.
For hypaconitine, the retention time was found to be
14.4 min with a m/z ratio of 616.311. The other compo-
nent peaks were identified based upon the m/z values
and information available in literature [27,35-37]. To
exclude the interferences of the endogenous and exogen-
ous substances that can be present in filtrate of cow
urine and cow milk after extraction, the list of compo-
nents identified in the blank controls with their m/z
values, retention times, and masses are mentioned in
Additional file 5: Table S2 (additional data file).
Reports in literature suggest that the DDA alkaloids
upon hydrolysis form MDA compounds. We found simi-
lar results in our previous unpublished studies related to
metabolite analysis of various Aconitum species [35-37].This conversion occurs by loss of groups as BzOH, H2O,
MeOH, and CO. The loss of these chemical group leads
to loss in masses of 122 Da, 18 Da, 32 Da, and 28 Da
respectively. The loss of acetic acid group is a characte-
ristic feature for formation of MDA compounds from
DDA compounds and results into a loss of 60 Da.
Through LC-MS analysis, the occurrence of this reaction
and formation of MDA compounds can be evidently
traced by detection of components with masses similar
to the MDA compounds. The MDA compounds formed
by molecular changes in DDA compounds are reported
in literature, and their m/z values are represented in
Additional file 6: Figure S5 (see additional data). In our
study we observed the formation of MDA compounds
such as benzoyl mesaconine and benzoyl aconine due to
hydrolysis reaction during processing. This is evident by
the presence of components with masses equal to the
reported mass values for these MDA compounds. The
LC-MS mass spectra of the filtrates were derived and
the formation of hydrolyzed constituents was ascer-
tained. The MDA compounds identified in the processed
drugs and the filtrates of mediums used for processing
are indicated by suitable abbreviations in LC-MS base
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Figure 3 Representative LC-MS chromatograms of marker compounds and solvent blank used in analysis (A) Extracted Compound
Chromatogram of marker compounds (B) MFE spectrum of markers indicating the m/z ratios (C) Base peak chromatogram of methanol
used as solvent (D) TIC overlay spectra of markers compounds. Abbreviations used: A- Aconitine, M-Mesaconitine, H-Hypaconitine.
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Table 1 Results of linearity studies
Parameters Aconitine Mesaconitine Hypaconitine
Calibration curve equation y = 33693.02x – 625.504 y = 29797.96x – 51913.504 y = 19022.440x – 24159.317
Correlation coefficient value (r2) 0.9988 0.9994 0.9990
LOD (ng mL-1) 0.383 0.438 0.088
LOQ (ng mL-1) 1.15 1.315 0.264
* All the determinations were performed in triplicate at 6 predetermined concentrations.
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Figure S5 (additional data) respectively. This provides
evidences for the scientific basis of traditional alchemy
of detoxification of Aconitum, caused by the hydrolytic
conversion of DDA to MDA compounds. To further
substantiate the claims of our study, the quantitation of
marker alkaloids in the processed and unprocessed drug
and the filtrates of various extraction mediums used,
was carried out. The estimated contents of the markers
in all the samples of each of the three selected species
are shown in Table 4. It was observed that, the process-
ing with water extracted the highest amount of marker
alkaloids into the solvent filtrate as compared to cow
urine and cow milk. The content of aconitine, mesaconi-
tine and hypaconitine in the decoction filtrates was
higher than their contents in the processed drug. In the
unprocessed drug sample, the content of aconitine,
mesaconitine and hypaconitine in A. heterophyllum was
lower as compared to A. kusnezoffii and A. carmichaelii.
Comparison of samples treated with cow milk
The LC-MS chromatogram of A. heterophyllum for unpro-
cessed drug (Figure 4A) compared to milk processed drug
(Figure 4B) shows a decrease in the number of toxic com-
ponents. We observed the formation of lipo-14-O-anisoyl-
bikhaconine, benzoylmesaconine, and benzoylaconine that
are distinctively present only in the processed drug sample
and not present in the unprocessed drug. Compounds be-
longing to the less toxic and monoester diterpene alkaloids




Content values*a (Mean ± S. D.) 4.372 ± 0.001
% RSD 0.037
Intraday precision
Content values*b (Mean ± S. D.) 4.160 ± 0.010
% RSD 0.243
*avalues for three replicate determinations; *bvalues for five replicate determinationignavine, isodelphinine, and delgrandine, were also ob-
served. The content of aconitine, mesaconitine and hypaco-
nitine in the unprocessed drug calculated in terms of dry
powder form was 11.310, 9.680 and 13.760 mg/kg which
were found to be reduced to 1.050, 1.964 and 0.943 mg/kg
respectively in the processed drug. This indicated that a
10–12 fold decrease in the content of selected DDA con-
tents occurred in the processed sample (see Table 4). The
milk filtrate obtained after treatment of the drug, (see
Additional file 1: Figure S1-A of additional data files) was
found to contain atisine, (−) salsolinol, senbusine, son-
goramine, senbusine-C and deltaline (the components
belonging to the more toxic class of aconitum alkaloids)
along with other less toxic compounds.
In the detoxification process of A. carmichaelii with cow
milk, the unprocessed drug profile (see Figure 5A) shows
presence of lesser number of components as compared to
the processed drug (Figure 5B). The content of aconitine,
mesaconitine and hypaconitine were found to be reduced
from 16.265, 15.305 and 16.245 mg/kg to 2.078, 1.047 and
1.797 mg/kg, respectively. An overall 8–15 fold decrease in
the content of the marker alkaloids was observed as shown
in Table 4. The milk filtrate was found to contain the toxic
components like hypaconitine, aconitine, mesaconitine, bei-
wutine, atisine, carmichaelline, (−) salsolinol, and songora-
mine, as seen in Additional file 1: Figure S1-B of the
additional data file. The formation of unknown compounds
U1 and U5 along with lipo-14-O-anisoylbikhaconine, ben-
zoylaconine, beiwutine and benzoylmesaconine was also
evident in processed Aconitum carmichaelii (see Figure 5B).Mesaconitine Hypaconitine
(ng mL-1) (ng mL-1)
4.764 ± 0.003 4.523 ± 0.004
0.064 0.107
4.608 ± 0.011 4.352 ± 0.020
0.249 0.477
s data were collected.
Table 3 Results of recovery studies
Accuracy Aconitine Mesaconitine Hypaconitine
*Mean ± S. D. *Mean ± S. D. *Mean ± S. D.
Low level Spike (50%)
Amount of standard added (ng) 2.200 2.460 2.260
Amount of standard recovered (ng) 2.313 ± 0.012 2.316 ± 0.002 2.203 ± 0.004
% Recovery 105.150 94.174 97.516
Intermediate level Spike (100%)
Amount of standard added (ng) 4.440 4.920 4.520
Amount of standard recovered (ng) 4.159 ± 0.007 5.326 ± 0.013 3.928 ± 0.010
% Recovery 93.671 108.250 86.920
High level Spike (150%)
Amount of standard added (ng) 6.640 7.380 6.78
Amount of standard recovered (ng) 6.573 ± 0.005 7.330 ± 0.006 6.474 ± 0.004
% Recovery 98.992 99.322 95.500
Avg. Recovery 99.271% 100.582% 93.312%
RSD % 0.057 0.070 0.060
*(n = 3) for each of the values mentioned for the above determinations.
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found to contain fewer components as compared to the
processed samples (see Figure 6A and B). This indicates
the possible formation of aconines and benzoylaconine
products along with other non-toxic components due to
hydrolysis. As observed in Additional file 1: Figure S1-C
of the additional data file, the milk extract of Aconitum
kusnezoffii contained (−) salosinol, mesaconitine, aconi-
tine, hypaconitine, beiwutine and the unknown compound
U5 in the unprocessed drug. In the processed drug (Fig-
ure 6B), benzoyl aconine, 14-O-veratoylneoline, isodelphi-
nine, lipo-14-O-anisoylbikhaconine, aconifine, lycoctonine
and bullatine B were found. The contents of aconitine,
mesaconitine and hypaconitine decreased from 14.405,
14.150 and 18.135 mg/kg to 3.960, 4.389 and 1.720 mg/kg,
respectively, indicating an overall 4–8 fold decrease in the
content of the alkaloidal components (see Table 4).
There are several reports which suggest that alkaloidal
components are easily extracted into milk [38-40], and
they are unstable at elevated temperatures [17]. Also, the
pH of milk (ca. pH 6.5) that is acidic compared to
plasma, leads to the transfer of basic compounds like
plant alkaloids into the milk [41]. We suggest that
affinity of alkaloids towards milk due to differences in
the pH and their instability at elevated temperatures are
the factors that support this ancient alchemical process
and our experimental hypothesis for the use of cow milk
in detoxification of aconitum roots.
Comparison of samples treated with cow urine
In the detoxification process with cow urine, it was
observed that the unprocessed drug of A. heterophyllum(see Figure 4A) has comparatively fewer peaks than
the processed drug (Figure 4C) and the urine filtrate
(Additional file 2: Figure S2-A of the additional data file).
Although not as efficient as milk, cow urine could also
essentially extract toxic components like (−) salsolinol,
atisine, deltaline, mesaconitine, aconitine, songoramine,
and benzoylaconine (as seen in Additional file 2: Figure
S2-A of the additional data file). As shown in Figure 4C,
processed A. heterophyllum contains the compounds ben-
zoylmesaconine, anthranoyllcoctonine, lipo-14-O-anisoyl-
bikhaconine and neojiangyouaconitine. The content of
markers in the processed drug showed a 3–4 fold decrease
from 11.310, 9.680 and 13.760 mg/kg to 4.700, 2.127 and
3.284 mg/kg for aconitine, mesaconitine and hypaconitine
compared to the unprocessed drug (Table 4).
Compared with the LC-MS BPC profile of unpro-
cessed A. carmichaelii (Figure 5A), the profile of urine
filtrate and the processed drug, both showed a marked
increase in number of components (Additional file 2:
Figure S2-B and Figure 5C). The urine filtrate was found
to contain benzoylaconine, songorine, mesaconitine,
beiwutine, hypaconitine, aconitine, 3-deoxyaconitine and
carmichaelline. The processed drug was found to con-
tain lipo-14-O-anisoylbikhaconine, aconifine, delbrusine,
14-O-anisoylneoline, and lycoctonine. A 3–4 fold reduc-
tion was observed in the initial concentration of the
toxic components compared with the unprocessed drug
(see Table 4). The contents of aconitine, mesaconitine
and hypaconitine were found to decrease to 5.536, 3.518
and 4.405 mg/kg, respectively.
In A. kusnezoffii, the unprocessed drug (Figure 6A)
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Figure 4 Representative LC-MS base peak chromatograms of roots of A. heterophyllum before and after processing (A) Unprocessed
sample (B) Processed with cow milk (C) Processed with cow urine (D) Processed with water. Abbreviations used: AT- Atisine, BW- Beiwutine, BA-
benzoylaconine, A- Aconitine, M-Mesaconitine, H-Hypaconitine, LP- Lipo-14-O-anisoylbikhaconine, S-(−) Salsolinol, SG-Songoramine, BMA- benzoylmesaconine.
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Figure 5 Representative LC-MS base peak chromatograms of roots of A. carmichaelii before and after processing (A) Unprocessed sample
(B) Processed with cow milk (C) Processed with cow urine (D) Processed with water. Abbreviations used: AT- Atisine, BMA- Benzoylmesaconine,
BA- Benzoylaconine, SB-Senbusine-A- Aconitine, H-Hypaconitine, LP-Lipo-14-O-anisoylbikhaconine, S-(−) Salsolinol, C- carmichaelline, BW-Beiwutine,
M-Mesaconitine.
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Figure 6 Representative LC-MS base peak chromatograms of roots of A. kusnezoffii before and after processing (A) Unprocessed
sample (B) Drug boiled in cow milk (C) Processed with cow urine (D) Processed with water. Abbreviations used: S-(−) Salsolinol, AT- Atisine,
SG- Songoramine, BA- Benzoylaconine, A- Aconitine, H-Hypaconitine, M-Mesaconitine, BW- Beiwutine, BMA- Benzoylmesaconine,
LP- Lipo-14-O-anisoylbikhaconine.
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Table 4 Content of toxic alkaloids in various processed and unprocessed samples of Aconitum roots
Sample Aconitine Mesaconitine Hypaconitine
(mg/kg) (mg/kg) (mg/kg)
*Mean ± S. D. *Mean ± S. D. *Mean ± S. D.
A. heterophyllum
Unprocessed drug material 11.310 ± 0.629 9.680 ± 0.327 13.760 ± 0.022
Drug processed with Cow milk 1.050 ± 0.146 1.964 ± 0.504 0.943 ± 0.016
Filtrate of cow milk decoction 0.274 ± 0.052 1.085 ± 0.62 0.361 ± 0.058
Drug processed with Cow urine 4.700 ± 0.034 2.127 ± 0.433 3.284 ± 0.856
Filtrate of cow urine extraction 5.209 ± 1.426 2.985 ± 0.798 4.076 ± 065
Drug processed with water 1.900 ± 0.002 0.962 ± 0.275 0.119 ± 0.032
Filtrate of aqueous decoction 2.198 ± 0.968 1.086 ± 0.724 0.212 ± 0.105
A. carmichaelii
Unprocessed drug material 16.265 ± 0.082 15.305 ± 0.605 16.245 ± 0.538
Drug processed with Cow milk 2.078 ± 0.002 1.047 ± 0.748 1.797 ± 0.049
Filtrate of cow milk decoction 4.284 ± 0.440 1.288 ± 0.249 1.039 ± 0.138
Drug processed with Cow urine 5.536 ± 0.008 3.518 ± 0.322 4.405 ± 0.122
Filtrate of cow urine extraction 1.361 ± 0.688 3.428 ± 0.127 6.177 ± 1.720
Drug processed with water 1.150 ± 0.445 1.729 ± 0.275 2.829 ± 0.007
Filtrate of aqueous decoction 2.615 ± 0.578 2.40 ± 0.775 3.174 ± 0.583
A. kusnezoffii
Unprocessed drug material 14.405 ± 0.386 14.150 ± 0.605 18.135 ± 0.229
Drug processed with Cow milk 3.960 ± 0.088 4.389 ± 0.060 1.720 ± 0.069
Filtrate of cow milk decoction 7.817 ± 1.707 8.502 ± 1.71 13.658 ± 4.21
Drug processed with Cow urine 11.125 ± 0.101 4.865 ± 0.220 3.088 ± 0.053
Filtrate of cow urine extraction 2.258 ± 0.231 6.689 ± 0.218 3.840 ± 0.33
Drug processed with water 2.050 ± 0.056 2.448 ± 0.150 1.067 ± 0.070
Filtrate of aqueous decoction 4.947 ± 1.749 4.086 ± 1.095 2.863 ± 0.817
*(n = 3) for each of the values mentioned for the above determinations.
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file) and the processed drug (Figure 6C). The cow urine
filtrate obtained after processing, shows the presence of
benzoylaconine, hypaconitine, aconitine, beiwutine, and
mesaconitine. The processed drug shows difference in
the presence of new components such as lipo-14-O-ani-
soylbikhaconine, senbusine-C, and delphatine. The LC-
MS profile observations showed a 4–6 fold decrease in
the content of toxic alkaloids, with decreased values of
aconitine, mesaconitine and hypaconitine as 11.125,
4.8653 and 3.088 mg/kg, respectively (see Table 4).
The ancient literature and modern scientific findings
suggest that cow urine can enhance the potency and
bioavailability of drugs, reduce toxicity and potentiate
the efficacy of drugs without itself acting as a drug
[42-52]. In our experiments, the cow urine used for pro-
cessing was found to have pH 6.9. The acidic pH of the
urine and exposure to heat through sunlight may be the
possible reasons for the detoxification reaction of aconi-
tum alkaloids.Comparison of samples treated by aqueous decoction
The Chinese pharmacopeia states several methods for
processing of aconite roots by treatment with mineral
salt, steaming and decoction with water [7]. We selected
the process of boiling with water for our study because
water is the most easily and widely available solvent and
because it is commonly used for detoxification of several
other drugs. The TCM method was found to be the
most effective method for detoxification as inferred from
the overall decrease observed in the toxic alkaloid
marker contents in comparison to the values obtained
for the other two methods of Shodhana (see Table 4).
For A. heterophyllum unprocessed drug, the results (see
Figure 4A) clearly show that there is an effective extrac-
tion of components in the aqueous filtrate. This may be
due to some hydrolytic reaction (Figure 4D). The com-
ponents extracted in the aqueous filtrate are greater in
number and more toxic in nature than the components
present in the processed drug (Additional file 3: Figure
S3-A of additional data file). Most of the components
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deltaline, mesaconitine, (−) salsolinol, hypaconitine, acon-
itine and songoramine, are toxic. The processed drug
contained the components anthranoyllcoctonine, neojian-
gyouaconitine, songorine, delgrandine, lipo-14-O-anisoyl-
bikhaconine and the unknown components U1 and U5.
There was a remarkable 10–12 fold decrease in the con-
tent of aconitine; mesaconitine and hypaconitine, with the
processed drug containing 1.900, 0.962, and 0.119 mg/kg
of the respective markers (see Table 4).
In case of A. carmichaelii, the unprocessed drug LC-
MS profile (Figure 5A) shows fewer components before
processing. Upon processing, the aqueous filtrate shows
the presence of the components benzoylmesaconine,
benzoylaconine, beiwutine, mesaconitine, aconitine, car-
michaelline, atisine and the unknown components U1
and U6 (as indicated in Additional file 4: Figure S3-B).
The processed drug profile (Figure 5D), shows the
presence of carmichaelline, beiwutine and non-toxic
components lipo-14-O-anisoylbikhaconine, dihydroati-
sine, senbusine B, senbusine C and the unknown com-
ponents named U1 and U6. There was a 15–16 fold
decrease in the toxic alkaloidal content of the unprocessed
drug, with the values for aconitine, mesaconitine and
hypaconitine obtained as 1.150, 1.729 and 2.829 mg/kg,
respectively.
Like the other two drugs, the unprocessed drug LC-
MS profile of Aconitum kusnezoffii (Figure 6A), has very
few components as compared to the processed drug and
the aqueous filtrate obtained from decoction. This sug-
gests an active hydrolytic conversion of the DDA’s to
MDA’s in the detoxification process. The aqueous filtrate
(see Additional file 3: Figure S3-C of additional data file)
was found to contain atisine, benzoylaconine, aconitine,
mesaconitine and hypaconitine, which belong to the
more toxic class of aconitine alkaloids. The processed
drug, along with reduced content of benzoylaconine, ben-
zoylmesaconine and (−) salsolinol, showed the presence of
14-O-veratoylneoline, hestisine, and lipo-14-O-anisoylbi-
khaconine (see Figure 6D). The aconitine, mesaconitine
and hypaconitine contents were found to decrease to
2.050, 2.448 and 1.067 mg/kg respectively indicating an
overall 7- fold decrease in the toxic alkaloid content.
After an extensive literature survey of constituents
reported in Aconitum species and after exclusion of
components found in the blank controls of solvents used
for processing, we found 5 unknown compounds whose
identity was not confirmed. The molecular features of
m/z value, molecular formula and UV max absorption
were obtained by UHPLC-Q-TOF/MS analysis. The
unknown compound U1 has retention time (tR) 5.32 mins
and m/z value 453.273. The molecular formula was found
to be C24H39NO7. Compound U2, was found to exhibit a
retention time (tR) 7.30 mins and m/z value 480.295. Themolecular formula was found to be C26H41NO7. Com-
pound U3 was found to have m/z value of 450.228 with
retention time (tR) 9.10 and with molecular formula as
C27H31NO5. The unknown compound U4 had a retention
time (tR) of 17.60 mins and m/z value of 628.349. The
molecular formula for U4 was found to be C30H57N15.
Compound U5 was found to have molecular formula of
C32H45NO10 with retention time (tR) 12.100 mins and m/z
value 626.294. The compounds U4 and U5 have molecular
weights closer to the reported diester and monoester alka-
loids. Thus we infer that they may belong to the monoes-
ter group of alkaloids formed after hydrolysis, caused due
to processing. Compound U6 was found to have a high
molecular m/z value of 850.570 with the molecular struc-
ture as C47H73NO11. This indicates that, U6 may possibly
belong to the high molecular weight lipoid group of alka-
loids, which is further substantiated by its delayed reten-
tion time (tR) of 26.50 mins. for elution. Due to lack of
sufficient literature and reference compounds, the exact
identity of the unknown compounds could not be estab-
lished. Nevertheless, the molecular characteristics esti-
mated from UHPLC-Q-TOF/MS analyses are shown in
Additional file 4: Table S1 (additional data).
There are several animal based studies which report
the lethal toxicity of unprocessed drug in comparison to
the processed drug in which the toxicity is drastically
reduced. Also several quantitative analysis methods re-
port the estimation of increase in the hydrolysed prod-
ucts like aconine, hypaconine and mesaconine in the
processed form of drug [53-60]. Hson-Mou and Paul
have compiled several studies for toxicity of many drugs
that include aconitum [61]. It states that in mice, when
the toxicities (LD50) of the processed pieces of Aconite
by oral and intravenous injection were tested the values
were found to be 17.42 and 3.516 g/kg respectively. And
overall, the toxicity level of the processed drug in com-
parison to the unprocessed raw drug was between 1/350
and 1/5 times. For oral dosage the LD50 was higher than
100 g/kg. Furthermore, there are no studies that report
the comparative detoxification studies of aconite by
TCM and Ayurveda method and the above discussed
reports further support the findings of our study.Experimental
Collection of plant material
The dried unprocessed roots of A. heterophyllum were ob-
tained from commercial Ayurvedic stores from Mumbai,
India and the unprocessed roots of A. carmichaelii, and A.
kusnezoffii were purchased from commercial herbal stores
in China. The authentication of all the plant materials
used for the study was carried out by Professor ZhongZ-
hen Zhao and the voucher specimens were deposited in
the Chinese Medicines Centre of Hong Kong Baptist
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for various processing methods.
Chemicals and reagents
Methanol and acetonitrile (HPLC grade) used as
solvents for the mobile phase were obtained from E.
Merck (Darmstadt, Germany). Formic acid (HPLC
grade - purity 96.0%) used as a modifier was pur-
chased from Tedia Company Inc (U.S.A.). Ultra-pure
water used in various procedures of the experiment
was obtained from a Milli-Q water purification system
(Millipore, Bedford, MA, U.S.A.). Standard aconitine,
mesaconitine, and hypaconitine were obtained from Tauto
Biotech Co. Ltd. Sanghai, China.
Detoxification processes of samples
All the three selected species of aconite roots were sub-
jected to the traditional Shodhana and TCM methods of
processing. The aim of the present work was to study
the effect of traditional processing methods on the
reduction of toxic contents of aconite. The factors like
particle sizes of the drug material, processing times and
shape of the roots, significantly affect the extraction of
analytes. To specifically depict the traditional detoxifica-
tion process and derive precise conclusions about the
changes occurring in constituents due to such process-
ing, we have used all the above mentioned parameters
for the process as mentioned in the traditional records,
and none of them were modified [7,25]. After the detoxi-
fication process all the dried processed forms of the drug
were powdered (mesh size 2–8), subjected to extraction
with chloroform and diluted with methanol prior to
analysis.
Also, the processing practice by common people or
traditional medicine practitioners would involve random
selection of roots of varying shapes. This is a crucial
aspect for a drug as aconitum where the toxicity varies
not only based upon the size but also the shape of the
roots. For instance, in the ancient TCM record “Origins
of the Materia Medica” (Ben Cao Yuan Shi, published in
1612) it is mentioned that the roots of A. carmichaelii
that have more number of projections and are large in
size will be more potent as compared to those which
have fewer projections [62]. We have found similar
results in one of our unpublished works, where we have
compared the toxic components of Aconitum roots of
various sizes and shapes. Thus, to avoid any bias occur-
ring due to particular shape, we have carried out random
sampling of the roots for this study.
For Shodhana treatment with cow urine, the coarse
powdered drug (mesh size 2–8) was kept immersed in
cow urine in a tray and exposed to direct sunlight for
3 days. Every 5.0 g of sample was immersed in about
60.0 mL cow urine. For Shodhana with cow milk, 5.0 gof each of the drugs were hung in bags made of muslin
cloth and placed in baths of boiling milk for 5 hours.
For the TCM method recorded in the Chinese phar-
macopoeia, the aconitum roots were macerated in water
for about 18 hours. After maceration, few roots were
representatively cut to check that there was no hard core
inside. The roots were soaked until there was no hard
core observed inside after cutting [7]. The roots were
then boiled in fresh water until there was no white core
observed in the larger size roots. This process required
approximately 6 hours in our experiments. The roots
were then allowed to air dry, cut into slices and dried.
Preparation of sample solutions
The processed drugs were powdered to uniform particle
size of (mesh size 2–8) for further extraction and analysis.
About 0.5 g sample powder was accurately weighed and
transferred into a 10-mL centrifuge tubes. About 5.0 mL
of chloroform was added and the mixture was sonicated
for 30 min, followed by centrifugation at 3000 rpm for
10 min. The obtained chloroform extracts were filtered
through 0.45 μm filters and diluted further with methanol
to obtain appropriate concentrations for analysis.
Preparation of standard solutions
Stock solutions of aconitine, mesaconitine and hypa-
conitine were prepared individually in methanol (HPLC
grade). Working solutions of standard compounds were
prepared by appropriate dilutions of respective stock so-
lutions to obtain concentration of 400 ng mL-1 each.
Serial dilutions of mixed standard solutions of aconitine,
mesaconitine and hypaconitine were prepared in the
range 2–100 ng mL-1 for calibration curve estimation.
Quantitative analysis by UHPLC-Q-TOF-MS
Ultra-performance liquid chromatography was carried out
using an Agilent 6540 accurate – mass Q-TOF LC/MS
(Agilent Technologies, U.S.A.) [63,64]. Separation of com-
ponents in the samples was performed at 20°C, using a
UPLC C18 analytical column (I.D. 1.7 μm, ACQUITY
UPLC® BEH, dimensions: 2.1 mm × 100 mm, Waters,
U.S.A.), attached with a C18 pre-column (2.1 mm ×
5 mm, I.D. 1.7 μm, VanGuard TM BEH, Waters, U.S.A.).
The mobile phase consisted of a mixture of water (A)
and acetonitrile (B), both containing 0.1% formic acid.
The optimized linear gradient elution was as follows: 0–
10 min, 5–25% B; 10–25 min, 25–75% B; 25–28 min,
75–100% B; 28–31 min, 100–100% B; 31–31.1 min,
100–5% B with 2.9 min of equilibrium time. The injec-
tion volume used for analysis was 2 μL. The flow rate
was kept constant at 0.4 mL/min. The acquisition of
mass spectra was done in positive mode by scanning
from 110 to 1700 in mass to charge ratio (m/z). The
operation parameters for MS analysis were as follows:
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40 psi, dry gas temperature 300°C, Vcap 4500, fragmen-
tor voltage 150 V and nozzle voltage 500 V.
The contents of aconitine, mesaconitine and hypaconi-
tine were estimated in the processed and unprocessed
samples. The average values of triplicate estimations of
the contents of marker compounds were calculated and
expressed as their amounts in processed and unpro-
cessed samples.
Validation of developed analytical method
The validation of the developed method was carried out
in accordance with the ICH guidelines - Q2R1 (ICH,
2005). The parameters considered for validation were
linearity, limit of detection (LOD) and limit of quantita-
tion estimation (LOQ), accuracy (recovery studies), and
precision (intraday, interday and repeatability) studies.
The linearity studies were carried out by 6 point cali-
bration method with triplicate analysis at each selected
concentration for all three standard compounds. Suitable
concentrations were selected and analyzed in order to
obtain a good correlation coefficient value (r2 ≥ 0.99).
The LOD and LOQ were estimated by analysis at sev-
eral concentrations of analytes, diluted appropriately to
estimate the lowest possible concentration that can be
detected and quantitated with the optimized experimen-
tal conditions. The standard deviations of the responses
and the slopes of the calibration curves were used to
obtain the value for LOD and LOQ of each of the
marker compounds.
Precision of the method was analyzed by three para-
meters, viz. interday-precision, intraday precision and
repeatability studies. Repeatability studies were carried
out by determinations of analytes in five injections of
samples. Intraday precision was carried out by determin-
ation of analytes concentration in sample injections on
the same day injected at five time intervals, namely, 0, 2,
4, 8 and 12 hrs. Interday precision was performed by
determination of analytes in samples once a day for 3
consecutive days. The% RSD for all the determinations
included in precision studies were calculated.
The accuracy of the developed method was estimated
by performing recovery studies at three different con-
centration levels in triplicate within the linear range of
the analytes. The recovery of the known added amount
of markers added to the samples with known concen-
trations of markers were calculated and expressed as
percentages of recovery.
Data analysis
The analysis of data was carried out with Agilent Mass
Hunter Workstation software-Qualitative Analysis (ver-
sion B 4.00, Build 4.0.479.5, Service Pack 3, Agilent
Technologies, Inc. 2011). The parameters adopted foranalysis were: peaks with height ≥ 2000 counts; extrac-
tion restricted retention time 1.0-25.0 min, charge state
considered was 1; peak spacing tolerance of 0.0025 m/z,
plus 7.0 ppm; compound relative height ≥ 2.5%, and
absolute height ≥ 1500 counts; for elements of C, H, O,
N from 3–60, 0–120, 0–30, 0–30 respectively for gener-
ating formulae. Results were indicated with the help of
base peak chromatograms (BPC with m/z range 150–
950) for each sample analysed. The statistical data ana-
lysis was performed by Graph Pad INSTAT software
(version 3.01).
Conclusions
In the present study, three detoxification strategies
comprising of Shodhana treatment with cow milk and
cow urine and TCM process of aqueous decoction were
compared. The order of efficiencies of the three pro-
cesses for detoxification can be stated as: Processing
with water > Shodhana with cow milk > Shodhana with
cow urine. From the study we can infer that all the three
methods of detoxification compared in this study are
efficient in detoxification. This is the first study to report
comparative study on the traditional experiences of pro-
cessing of Aconite roots between Ayurveda and TCM.
Also, to the best of our knowledge, this is the first study
to explore the chemical profile of aconitum roots after
treating by two forms of Shodhana (an ancient Ayurveda
detoxification process) and for quantitation of the toxic
alkaloids before and after processing.
We have applied these ancient methods of detoxifica-
tion from traditional systems of two different countries
and substantiated their validity through comparative
experimental evidence. The developed analysis method
finds its distinction in being the first study to demonstrate
the comparative quantitative analysis and method valid-
ation of Shodhana treated aconitum by using the
advanced and sensitive technique UHPLC-Q-TOF-MS.
An easy and effective detoxification process by use of
readily available solvents like water, cow urine and cow
milk is suggested, and the process can be carried out easily
by the consumers themselves. The present study provides
better understanding of the processing of herbal drugs
and can contribute towards the convergence of the an-
cient wisdom from different geographical and scientific
backgrounds, thus supporting the concept of globalization
of herbal medicine.
Additional files
Additional file 1: Figure S1. Representative LC-MS base peak
chromatograms of milk filtrate after Shodhana treatment of aconite roots
(A) A. heterophyllum (B) A. carmichaelii (C) A. kusnezoffii (D) Cow milk
filtrate used as control. Abbreviations used: S-(-) Salsolinol, AT- Atisine,
BA- Benzoylaconine, BMA-Benzoylmesaconine, SG- Songoramine, BW-
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http://journal.chemistrycentral.com/content/7/1/169Beiwutine, M-Mesaconitine, BW- Beiwutine , C- carmichaelline, LP- Lipo-14-
O-anisoylbikhaconine, SBC- Senbusine-C, A- Aconitine, H- Hypaconitine.
Additional file 2: Figure S2. Representative LC-MS base peak
chromatograms of cow urine filtrate after Shodhana treatment of aconite
roots (A) A. heterophyllum (B) A. carmichaelii (C) A. kusnezoffii (D) Cow
urine used as control. Abbreviations used: C- carmichaelline, AT- Atisine,
BA- Benzoylaconine, BW- Beiwutine, M-Mesaconitine, A- Aconitine,
SB- Senbusine-C, SG- Songoramine, H- Hypaconitine.
Additional file 3: Figure S3. Representative LC-MS base peak
chromatograms of aqueous filtrate after TCM treatment of aconite roots
(A) A. heterophyllum (B) A. carmichaelii (C) A. kusnezoffii (D) Water used as
control. Abbreviations used: S-(-) Salsolinol, AT- Atisine, BA- Benzoylaconine,
BW- Beiwutine, M-Mesaconitine, A- Aconitine, H-Hypaconitine, BMA-
Benzoylmesaconine, LP- Lipo-14-O-anisoylbikhaconine, SB- Senbusine – B.
Additional file 4: Table S1. Data for peaks of various constituents
identified in the three selected Aconitum species. Footnote: Key: U1-U6
are the unknown constituents detected in various samples of selected
Aconitum species.
Additional file 5: Table S2. List of molecular features of constituents
present in the filtrate of cow milk and cow urine used for extraction of
aconitum samples.
Additional file 6: Figure S5. Representation of the mechanism of
formation of MDA compounds from DDA components of Aconitum
alkaloids by successive loss of chemical groups and respective changes
in m/z values.
Additional file 7: Figure S4. Representative LC-MS-ESI scan spectra of
various filtrates obtained after processing A. carmichaelii for depicting
conversion of DDA compounds to MDA. (A) Unprocessed drug (B) Filtrate
obtained after extraction with Cow urine (C) Filtrate obtained after
extraction with Cow milk (D) Filtrate obtained after extraction with water.
The MDA components and hydrolyzed products formed from DDA
compounds are indicated with a red asterisk (*) symbol.
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